{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:32:54Z","timestamp":1725355974758},"reference-count":16,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"vor","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Gilead"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jacc.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T20:19:13Z","timestamp":1362946753000},"page":"2046-2047","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes and Coronary Disease"],"prefix":"10.1016","volume":"61","author":[{"given":"Wilbur Y.W.","family":"Lew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony N.","family":"DeMaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.03.002_bib1","first-page":"918","article-title":"Increasing prevalence of diagnosed diabetes\u2014United States and Puerto Rico, 1995\u20132010","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacc.2013.03.002_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.167.11.1145","article-title":"Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease","volume":"167","author":"Franco","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2013.03.002_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.03.002_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacc.2012.11.036","volume":"61","author":"Dagenais","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2012.11.035","article-title":"Ischemia dictates outcome, not symptoms","volume":"61","author":"Stone","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2008.12.053","volume":"53","author":"Scirica","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib7","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrcardio.2011.129","article-title":"Stable angina pectoris: antianginal therapies and future directions","volume":"9","author":"Chaitman","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2011.11.003","article-title":"Role of ranolazine in angina, heart failure, arrhythmias, and diabetes","volume":"133","author":"Sossalla","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2013.03.002_bib10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.03.002_bib12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/eurheartj\/ehi495","article-title":"Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes","volume":"27","author":"Timmis","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.03.002_bib14","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","article-title":"Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial","volume":"119","author":"Morrow","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.03.002_bib15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.03.002_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2012.10.051","article-title":"Effect of ranolazine on arterial endothelial function in patients with type 2 diabetes mellitus","volume":"226","author":"Lamendola","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713009273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713009273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T13:56:02Z","timestamp":1597845362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713009273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":16,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0735109713009273"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.03.002","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}